BIOMOL International is a brand of Enzo Life Sciences International, Inc., a wholly-owned subsidiary of Enzo Biochem. Incorporating the Alexis Biochemicals and BIOMOL brands, Enzo Life Sciences is organised to lead in the development, production, marketing and sales of innovative life science research reagents worldwide.

BIOMOL International has been an innovator in providing superior, cutting-edge reagents for biomedical research for over 25 years. BIOMOL has been focused on researcher’s success since the release of leukotrienes in 1983, through the introduction of the first pathway-specific signal transduction catalogue to today’s offering of over 3500 products and services.

Within Enzo Life Sciences, BIOMOL is a major research, development and production centre, developing and producing innovative products for:

• Signal Transduction
• Lipid Signalling
• Post Translational Modifications
• Proteolysis
• Ubiquitin & Ubiquitin-like Protein Signalling

BIOMOL maintains in-house laboratories staffed with an experienced research & development team of organic chemists, biochemists, cell biologists, pharmacologists and molecular biologists with the expertise to develop and support the innovative products that biomedical research requires. Capabilities include organic chemical synthesis, peptide synthesis, recombinant protein production, antibody production and assay development.